Recent progress in the treatment of lupus nephritis

Modern Rheumatology
Antonis FanouriakisDimitrios T Boumpas

Abstract

The treatment of lupus nephritis has seen significant advances during the past decade mainly due to the publication of well-designed randomized clinical trials (RCTs). The choice of treatment is guided by the histopathologic classification but is also influenced by demographic, clinical, and laboratory characteristics that allow for the identification of patients at risk for more aggressive disease. For the induction arm, low-dose cyclophosphamide regimens and mycophenolate mofetil have been validated as alternatives to the established National Institutes of Health regimen of high-dose cyclophosphamide; for the maintenance phase, azathioprine and mycophenolate compete for treatment of first choice. Rituximab is efficacious in real-life clinical practice but ineffective in clinical trials. The role of recently approved belimumab in lupus nephritis eagerly awaits further documentation. Aggressive management of comorbid conditions, such as hypertension and dyslipidemia, is of utmost importance. Here, we review the latest advances in lupus nephritis therapy with a focus on recent RCTs as well as new biologic agents under development. Furthermore, we propose a therapeutic algorithm in an effort to facilitate clinical decision-making...Continue Reading

References

Mar 6, 1986·The New England Journal of Medicine·H A AustinJ L Decker
May 31, 2001·Kidney International·C C NajafiUNKNOWN Lupus Nephritis Collaborative Study Group
Mar 5, 2004·The New England Journal of Medicine·Gabriel ContrerasDavid Roth
Feb 25, 2005·Journal of the American Society of Nephrology : JASN·Tak-Mao ChanUNKNOWN Hong Kong Nephrology Study Group
Nov 25, 2005·The New England Journal of Medicine·Ellen M GinzlerGerald B Appel
Jul 6, 2006·Kidney International·C GrootscholtenUNKNOWN Dutch Working Party on Systemic Lupus Erythematosus
Aug 15, 2006·Annals of the Rheumatic Diseases·G S AlarcónUNKNOWN LUMINA Study Group
Mar 31, 2007·Kidney & Blood Pressure Research·Zuzana RihovaVladimir Tesar
May 1, 2007·Arthritis and Rheumatism·Peter E WesterweelMarianne C Verhaar
Jul 4, 2008·Journal of the American Society of Nephrology : JASN·Hao BaoLei-Shi Li
Jul 30, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Anke Rietveld, Jo H M Berden
Dec 24, 2008·Annals of the Rheumatic Diseases·G Ruiz-IrastorzaM A Khamashta
Apr 1, 2009·Arthritis and Rheumatism·Gudrun E NorbyUNKNOWN Assessment of Lescol in Renal Transplantation Study Group
Apr 17, 2009·Journal of the American Society of Nephrology : JASN·Gerald B AppelUNKNOWN Aspreva Lupus Management Study Group
May 30, 2009·Arthritis and Rheumatism·Guillermo J Pons-EstelUNKNOWN Lumina Study Group
Dec 18, 2009·Kidney & Blood Pressure Research·Cheng-Hao WengCheng-Chieh Hung
Mar 2, 2010·Arthritis Care & Research·Mikkel FaurschouSøren Jacobsen
Apr 21, 2010·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Hideki ShimazuMasanori Funauchi
Jul 9, 2010·Nephrology·Olugbenga Edward AyodeleCharles R Swanepoel
Sep 14, 2010·Annals of the Rheumatic Diseases·Frédéric A HoussiauUNKNOWN MAINTAIN Nephritis Trial Group
Nov 6, 2010·Journal of the American Society of Nephrology : JASN·Andrew S Bomback, Gerald B Appel
Mar 4, 2011·Annals of the Rheumatic Diseases·Thórunn JónsdóttirIva Gunnarsson

❮ Previous
Next ❯

Citations

Jun 1, 2013·Journal of the American Society of Nephrology : JASN·Hua ZhouGabor G Illei

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
W Joseph McCune
Current Opinion in Nephrology and Hypertension
Jonathan Hogan, Gerald B Appel
The New England Journal of Medicine
Frederic A Houssiau
Current Rheumatology Reports
Katrina Shum, Anca Askanase
© 2021 Meta ULC. All rights reserved